Alerts will be sent to your verified email
Verify Email
FDC
|
FDC
|
Zota Health Care
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
5.1 % | n/a | n/a |
|
R&D as a % of Total Sales
|
2.22 % | 0.09 % | 1.84 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.9 % | -7.74 % | 23.7 % |
|
5yr average Equity Multiplier
|
1.57 | 1.84 | 2.62 |
|
5yr Average Asset Turnover Ratio
|
0.55 | 0.91 | 0.6 |
|
5yr Avg Net Profit Margin
|
15.2 % | -4.95 % | 12.9 % |
|
Price to Book
|
2.52 | 13.69 | 2.79 |
|
P/E
|
27.2 | 0.0 | 15.06 |
|
5yr Avg Cash Conversion Cycle
|
-13.89 Days | 40.5 Days | -51.45 Days |
|
Inventory Days
|
61.89 Days | 91.82 Days | 69.05 Days |
|
Days Receivable
|
18.98 Days | 42.2 Days | 60.35 Days |
|
Days Payable
|
89.17 Days | 92.36 Days | 225.58 Days |
|
5yr Average Interest Coverage Ratio
|
90.41 | 5.98 | 0.72 |
|
5yr Avg ROCE
|
13.8 % | -2.72 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
17.7 % | 3.69 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.04 | 1.01 |
|
5yr CAGR Net Profit
|
-2.41 % | 206.06 % | 68.01 % |
|
5yr Average Return on Assets
|
8.22 % | -3.4 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 50.64 % | 27.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.26 % | 30.6 % |
|
Change in Promoter Holding (3 Yrs)
|
0.17 % | -17.48 % | -3.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.33 % | 0.42 % | -3.06 % |
|
FDC
|
Zota Health Care
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|